(Total Views: 552)
Posted On: 07/13/2022 5:23:16 PM
Post# of 151733
Thanks for posting a link to a good early overview.
From the article.
Leronlimab resets that.
Inflammatory conditions increase leakage in the blood brain barrier. Leronlimab can fix that.
Leronlimab downregulates those.
Leronlimab can reverse the overreaction of autoantibodies.
They list some potential drugs for long-COVID treatment including leronlimab. But those drugs treat narrow symptomologies and leronlimab will do what they all do individually.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277229/
From the article.
Quote:
elevated inflammatory cytokines, as well as clotting disorders
Leronlimab resets that.
Quote:
Nath speculates that, among COVID-19 survivors, “leaky vessels might allow the entry of toxic blood compounds into the brain that lead to permanent or long-term symptoms.”
Inflammatory conditions increase leakage in the blood brain barrier. Leronlimab can fix that.
Quote:
Liam O’Mahony, an immunologist at APC Microbiome Ireland, a research center based at University College Cork, is publishing a study showing that inflammatory markers, such as interleukin (IL)-6, tumor necrosis factor (TNF)-α, and C-reactive protein, were elevated in blood plasma... His research also shows that polarizing markers of adaptive immunity, including IL-17 and IL-4, are elevated in long-COVID.
Leronlimab downregulates those.
Quote:
Finally, scientists are investigating the possibility that long-COVID symptoms might arise in some cases from autoantibodies attacking the body’s own cells.
Leronlimab can reverse the overreaction of autoantibodies.
They list some potential drugs for long-COVID treatment including leronlimab. But those drugs treat narrow symptomologies and leronlimab will do what they all do individually.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277229/
(18)
(0)Scroll down for more posts ▼
